Radiopharm Theranostics Files Routine 6-K
Ticker: RDPTF · Form: 6-K · Filed: May 30, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Radiopharm Theranostics filed a 6-K, just routine reporting.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on May 30, 2025, reporting information for the month of May 2025. The company, based in Carlton South, Victoria, Australia, is a foreign private issuer and files annual reports under Form 20-F. This filing does not appear to contain specific financial figures or significant operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Radiopharm Theranostics is fulfilling its reporting obligations as a foreign private issuer with the SEC, which is standard practice for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information that would typically impact risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- 20250530 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is Radiopharm Theranostics Limited.
What is the company's principal executive office address?
The address is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does the company file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
Is the company furnishing information under Rule 12g3-2(b)?
No, the company is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).